ExpreS2ion Biotechnologies
1 clinical trials · Sponsor
◉ Watch ExpreS2ion Biotechnologies
| Record | Firm | Date |
|---|---|---|
| A First-in-human, Clinical Trial Assessing the Safety of ES2B-C001-S01 With or Without [Adjuvant] in Patients With HER2-expressing Metastatic Breast Cancer. (NCT06746688) | ExpreS2ion Biotechnologies | 2025-06-03 |
Track ExpreS2ion Biotechnologies automatically
Every clearance here is in the API, with alerts when new ones post.